Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Theolytics logo — Transforming patients’ lives | Through world leading science...

Theolytics

Transforming patients’ lives | Through world leading science | With a great team

Founded 2017 United Kingdom Oxford, United Kingdom 31 employees Venture round Total: $50.40M Biotechnology, Health and Wellness

General Information

Company Name Theolytics
Founded Year 2017
Location United Kingdom Oxford, United Kingdom
Founders / Decision Makers
Team member
Employees 31
Industries Biotechnology, Health and Wellness
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Theolytics. To contact Theolytics, visit theolytics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Theolytics compare?

A PDF of Theolytics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Theolytics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Theolytics

Theolytics, a biotechnology company based in the United Kingdom, is dedicated to transforming patients’ lives through world-leading science and a great team. Founded in 2017, Theolytics is at the forefront of oncolytic viral therapy, harnessing viruses to combat cancer. The company's phenotypic screening Platform represents a significant advancement in the field, enabling the discovery and development of targeted candidates suitable for intravenous delivery and optimized for specific patient populations. In addition to advancing an internal pipeline of programs spanning both solid and liquid tumors, Theolytics has secured a significant £19.00M Venture Round investment on 17 April 2024. Notable investors involved in this round include Epidarex Capital, MERL Ventures Fund, Oxford Science Enterprises, Taiho Ventures, Sound Bioventures, and the University of Oxford. The company is also establishing strategic partnerships to further expand and accelerate pipeline development in the biotechnology industry. In summary, Theolytics stands out for its innovative approach to leveraging viruses for cancer treatment, evidenced by its recent substantial investment and prominent investor involvement. As it continues to make advancements in the field and build strategic collaborations, Theolytics holds significant potential in the biotechnology sector.

Business keywords: Oncolytic viral therapy, Phenotypic screening platform, Cancer treatment, Adenoviral therapy, Clinical stage biotechnology, Pipeline development, Solid tumors, Liquid tumors, Virology, Partnerships, Intravenous delivery, Patient population, Disease combat, Science innovation

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £19.00M 6
Epidarex Capital MERL Ventures Fund Oxford Science Enterprises
Epidarex Capital, MERL Ventures Fund +4
17 Apr 2024
Series A £22.10M 4
MERL Ventures Fund Oxford Science Enterprises Taiho Ventures
MERL Ventures Fund, Oxford Science Enterprises +2
25 Aug 2023
Series A $6.80M -
07 Jan 2021
Seed Round £2.50M -
01 Dec 2017

Theolytics Alternatives & Competitors

View All Alternatives
Theolytics vs
Turnstone Biologics
Turnstone Biologics United States

Developing next-generation TIL-based therapies to treat and cure solid tumors.

Series D
64 employees
Biotechnology, Health and Wellness
Compare Theolytics vs Turnstone Biologics
Theolytics vs
TC BioPharm
TC BioPharm United Kingdom

Treating cancer with γδ T cells | Nasdaq Ticker - $TCBP

Post-IPO Equity
51 employees
Biotechnology, Health Care
Compare Theolytics vs TC BioPharm
Theolytics vs
Carisma Therapeutics
Carisma Therapeutics United States

Pioneering CAR Macrophage Immunotherapy to Target Solid Tumors

Acquired
15 employees
Biotechnology, Health Care
Also compare with: Theolytics vs ProfoundBio ProfoundBio View all alternatives

FAQ About Theolytics

Transforming patients’ lives | Through world leading science | With a great team
Theolytics was founded in 2017.
Theolytics is headquartered in Oxford, United Kingdom.
Theolytics operates in Biotechnology and Health and Wellness. Its work centres on Oncolytic viral therapy, Phenotypic screening platform, Cancer treatment and Adenoviral therapy.
Theolytics has approximately 31 employees.
Theolytics has completed 4 funding rounds, raising a total of $50.40M. The latest funding stage is Venture round.
Top alternatives and competitors to Theolytics include Turnstone Biologics, TC BioPharm , Carisma Therapeutics, ALX Oncology, Simcha Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Theolytics and Turnstone Biologics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Theolytics, https://bouncewatch.com/company/theolytics, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout